Research Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Evaluating the impact of autoimmune conditions on the outcomes of patients with lymphoma

Posted by on Dec 13, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the impact of autoimmune conditions on the outcomes of patients with lymphoma. This study concluded that these conditions may negatively impact survival outcomes for these patients. Some background Autoimmune conditions are a group of diseases where the immune system attacks the body’s healthy tissues. One...

Read More

Evaluating the impact of autoimmune conditions on the outcomes of patients with lymphoma

Posted by on Dec 13, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the impact of autoimmune conditions on the outcomes of patients with lymphoma. This study concluded that these conditions may negatively impact survival outcomes for these patients. Some background Autoimmune conditions are a group of diseases where the immune system attacks the body’s healthy tissues. One...

Read More

Is MRD related to treatment and survival in patients with chronic lymphocytic leukemia?

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study wanted to compare the effectiveness of chlorambucil (Leukeran) plus either obinutuzumab (Gazyva) or rituximab (Rituxan) in the treatment of frail patients with chronic lymphocytic leukemia (CLL). Researchers found that chlorambucil with obinutuzumab (G-Clb) was more effective than with rituximab (R-Clb) in these...

Read More

Survival from transplant of donor bone marrow versus donor blood sample in leukemia treatment

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of donor peripheral blood (PB) with bone marrow (BM) transplant in the treatment of leukemia. Researchers found that bone marrow transplants are safer and more effective in the treatment of leukemia. Some background Leukemia is a cancer of the bone marrow. It may lead to abnormal immune...

Read More

Rectal cancer: short- and long-term outcomes of robotic assisted laparoscopic surgery

Posted by on Dec 12, 2018 in Colorectal cancer | 0 comments

In a nutshell This article investigated the short- and long-term outcomes of patients with rectal cancer who underwent robotic-assisted laparoscopic surgery (RALS). The authors concluded that RALS is beneficial and has good short- and long-term outcomes.  Some background Conventional laparoscopic surgery (CLS; involves small cuts...

Read More

Lower fat diet associated with diabetic eye disease in type 1 diabetes

Posted by on Dec 12, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to look at the differences in the diets of people with type 1 diabetes (T1D) with and without diabetic retinopathy (DR; eye damage). The main finding of the study was that a higher fat intake was associated with lower frequency of DR. Some background DR is a type of eye disease that can occur in patients with T1D. If it...

Read More

Effectiveness of dutasteride and solifenacin used to treat benign prostatic hyperplasia

Posted by on Dec 12, 2018 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to investigate the effects of combining dutasteride (Avodart) and solifenacin (Vesicare) on sexual function in men being treated for benign prostatic hyperplasia (BPH). This study found that the combination of dutasteride and solifenacin does not alter sexual function for men with BPH. Some...

Read More

Adding ixabepilone to capecitabine treatment for triple negative breast cancer.

Posted by on Dec 11, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if ixabepilone (Ixempra) and capecitabine (Xeloda) work for treating triple-negative breast cancer in patients with hard to treat disease compared to using capecitabine alone. The study found that adding ixabepilone to treatment resulted in longer survival without the cancer progressing. Some background...

Read More